Centrifugal leukocyte apheresis for ulcerative colitis

Therapeutic Apheresis

Volumn 2, Issue 2, 1998, Pages 125-128

  Ayabe, Tokiyoshi ^a   Ashida, Toshifumi ^a   Kohgo, Yutaka ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Apheresis; Corticosteroid; Inflammatory bowel disease; Leukocytapheresis; Leukocyte; Resistance; Response; Ulcerative colitis

Indexed keywords

CORTICOSTEROID;

ADULT; ARTICLE; CLINICAL ARTICLE; DEVICE; DISEASE ACTIVITY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LEUKAPHERESIS; LONG TERM CARE; MALE; PRIORITY JOURNAL; RELAPSE; REMISSION; TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME; ULCERATIVE COLITIS;

EID: 0031807459     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1744-9987.1998.tb00089.x     Document Type: Article

References (15)

1. Ayabe T, Ashida T, Taniguchi M, Nomura M, Einami K, Taruishi M, Saitoh Y, Santos BS, Ono M, Shibata Y, Kohgo Y. A pilot study of centrifugal leukocyte apheresis for corticosteroid-resistant active ulcerative colitis. Intern Med 1997; 36:322.
2. Bicks RC, Groshart KW, Chandler RW. The treatment of severe chronically active Crohn's disease by T8 (suppressor cell) lymphocytapheresis. Gastroenterology 1985;88:A1325.
3. Lerebours E, Bussel A, Modiglian R, et al. Treatment of Crohn's disease by lymphocyte apheresis: A randomized controlled trial. Gastroenterology 1994;107:357.
4. Wallace DW, Goldfinger D, Lowe C, Nichols S, Weiner J, Brachman M, Klinenberg JR. A double-blind, controlled study of lymphoplasmapheresis versus sham apheresis in rheumatoid arthritis. N Engl J Med 1982;306:1406.
5. Dwosh IL, Giles AR, Ford PM, Pater JL, Anastassiades TP. Plasmapheresis therapy in rheumatoid arthritis: A controlled, double blind, crossover trial. N Engl J Med 1983;308:1124.
6. Miller FW, Leitman SF, Cronin MF, Hicks JE, Leff RL, Wesley R, Fraser DD, Dalakas M, Plots PH. Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis. N Engl J Med 1992;326:1380.
7. Sawada K, Ohnishi K, Fukui S, Ayabe T, Ashida T, Kongo Y. Leukocytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel disease. J Gastroenterol 1995;30:322.
8. Das KM, Dasgupta A, Mandal A, Geng X. Autoimmunity to cytoskeletal protein tropomyosin. J Immunol 1993;150: 2487-93.
9. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993;75:253.
10. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomized trial. Br Med J 1989;298:82.
11. Matts SGF. The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med 1961;120:393.
12. Chadwick VC. Lymphocyte apheresis in Crohn's disease. Gastroenterology 1994;107:579.
13. Ayabe T, Ashida T, Taniguchi M, Honda M, Fujiki T, Nomura M, Einami K, Taruishi M, Watari J, Saoyoh Y, Santos SB, Shibata Y, Kohgo Y. Centrifugal leukocyte apheresis as an effective therapeutic procedure for corticosteroid-resistant active ulcerative colitis. Gastroenterology 1997;112:A926.
14. Podolsky DK, Lobb R, King N, et al. Attenuation of colitis in the cotton-top tamarin by anti-alpha 4 integrin monoclonal antibody. J Clin Invest 1993;92:372.
15. Taniguchi M, Ayabe T, Ashida T, et al. Soluble L-selectin as a new serological indicator for ulcerative colitis. Gastroenterology 1996;110:A1025.